Plymouth
Pharmaceuticals™, Inc. and its division,
Loma Lux Laboratories,
is dedicated to promoting worldwide health and wholeness. Our focus
is the discovery, research, and development of natural,
low dose, low side effect treatments that bring freedom
from chronic diseases through correction of basic underlying
disease mechanisms. Responsible manufacturing practices, integrity
of our advertisements, and prompt, efficient service are central
to our corporate philosophy. Furthermore, it is our mission to make
these treatments widely and easily available to those who need them.
Plymouth
Pharmaceuticals™. was incorporated in 1991 under
the direction of Steven A. Smith, M.D. (see bio
below), a dermatologist, and launched its first RX product, Psorizide®
Ultra, in the mid 1990’s to treat psoriasis, eczema, and seborrhea.
Psorizide® Ultra was then reformulated for the treatment of
psoriasis specifically and became Psorizide® Forte in 2001;
at that time Psorizide® Ultra’s indication became solely
the treatment of eczema and seborrhea. Eczemol® for the treatment of moderate to severe eczema, and Acunol™, for the treatment of mild to moderate acne were launched in 2006. Plymouth Pharmaceuticals™ currently
also distributes a line of OTC products for various conditions under
the dba Loma Lux® Laboratories;
these products have distribution in Target nationwide.
|
|

Dr. Smith
received his BA in 1975 from Indiana Wesleyan University (Marion,
Indiana) and his MD in 1979 from Indiana University School
of Medicine (Indianapolis, Indiana). Dr. Smith completed an
Internal Medicine Internship in 1980, an Internal Medicine
Residency in 1982, and a Dermatology Residency in 1984, all
at the University of Texas Health Science Center (San Antonio,
TX).
|
|
| Dr.
Smith is a board certified dermatologist (American Board of
Dermatology, 1985) and a board certified internist (American
Board of Internal Medicine, 1982).
Dr.
Smith is a Fellow of the American College of Physicians, American
Academy of Dermatology, and American Society of Dermatological
Surgery. He is a member of Alpha Omega Alpha Medical Honor
Society, American Medical Association, Oklahoma State Medical
Association, Oklahoma State Dermatological Society, Tulsa
County Medical Society, Tulsa Dermatological Society, International
Society of Dermatology, and International Society of Dermatological
Surgery. In addition, he received the Outstanding Achievement
Award in Science and Health from Indiana Wesleyan University
in 1993.
Dr.
Smith currently serves as Clinical Associate Professor of
Dermatology at the University of Oklahoma College of Medicine
in Tulsa, Oklahoma. Dr. Smith also currently serves as active
staff at St. John's Medical Center, Hillcrest Medical Center
St. Francis Hospital and Tulsa Regional, all in Tulsa, Oklahoma.
Board of Directors, Tulsa County Medical Society, 2003
Previously,
Dr. Smith served as President of the Oklahoma State Dermatological
Society (1988-1989), Assistant Professor of Dermatology at
Oral Roberts University School of Medicine, Tulsa, Oklahoma
(1985-1988), Assistant Instructor of Dermatology at the University
of Texas Health Science Center, San Antonio, Texas (1983-1984),
and Secretary/Treasurer of the Oklahoma State Dermatological
Society (1986-1987).
|
|
|
 |